Technical information
Manufacturer
THERATECHNOLOGIES INTERNATIONAL LIMITED
Presentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
y5L68k6bXHARMY1m